approved

Приложение 4 на ПЛС от 02.08.2020 г.

Unique identificator:  4cf24e0d-723c-4ee6-8f1f-85079e7c20cf

Current version: 1

Displayed version: 1

Format: CSV

  • Created at: 2020-08-06 16:31:04
  • Created by: georgi_sivchev
  • Updated at: 2020-08-06 16:31:04
records per page
Order by:

ПОЗИТИВЕН ЛЕКАРСТВЕН СПИСЪК

Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1563.84 312.77 1876.61 4% 10 1573.84 314.77 1888.61 16% 25 1598.84 319.77 1918.61 НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение 22.11.2019 02.01.2020 Неактивен 16292
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1563.84 312.77 1876.61 4% 10 1573.84 314.77 1888.61 16% 25 1598.84 319.77 1918.61 НСР-16864/28.09.2018; НСР-20222/22.11.2019 Предварително изпълнение* 22.11.2019 02.12.2019 Неактивен 16292
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1647.81 329.56 1977.37 4% 10 1657.81 331.56 1989.37 16% 25 1682.81 336.56 2019.37 НСР-16864/28.09.2018 13.10.2018 02.11.2018 Неактивен 16292
Tocilizumab EU/1/08/4 92/009 RoActemra, Solution for injection, 162, mg, Pack: 4 pre-filled pens Roche Registration GmbH, Германия Roche Pharma AG, Germany 1647.81 329.56 1977.37 4% 10 1657.81 331.56 1989.37 16% 25 1682.81 336.56 2019.37 НСР-16864/28.09.2018 13.10.2018 02.11.2018 Неактивен 16292
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 514.91 102.98 617.89 4% 10 524.91 104.98 629.89 16% 25 549.91 109.98 659.89 Промяна на обстоятелствата НСР-15987/22.06.2018. НСР-5077/21.11.2014; НСР-13342/28.07.2017 12.08.2017 02.08.2018 Активен 3377
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 514.91 102.98 617.89 4% 10 524.91 104.98 629.89 16% 25 549.91 109.98 659.89 Промяна на обстоятелствата НСР-15987/22.06.2018. НСР-5077/21.11.2014; НСР-13342/28.07.2017 12.08.2017 02.08.2018 Неактивен 3377
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 1029.82 205.96 1235.78 4% 10 1039.82 207.96 1247.78 16% 25 1064.82 212.96 1277.78 Промяна на обстоятелствата НСР-15986/22.06.2018. НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 02.12.2017 02.08.2018 Активен 3378
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 1029.82 205.96 1235.78 4% 10 1039.82 207.96 1247.78 16% 25 1064.82 212.96 1277.78 Промяна на обстоятелствата НСР-15986/22.06.2018. НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 02.12.2017 02.08.2018 Неактивен 3378
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 205.97 41.19 247.16 4% 8.24 214.21 42.84 257.05 16% 25 239.21 47.84 287.05 Промяна на обстоятелствата НСР-15983/22.06.2018. НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 02.12.2017 02.08.2018 Активен 3376
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration GmbH, Германия Roche Pharma AG Germany 205.97 41.19 247.16 4% 8.24 214.21 42.84 257.05 16% 25 239.21 47.84 287.05 Промяна на обстоятелствата НСР-15983/22.06.2018. НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 02.12.2017 02.08.2018 Неактивен 3376
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 205.97 41.19 247.16 4% 8.24 214.21 42.84 257.05 16% 25 239.21 47.84 287.05 НСР-5076/21.11.2014; НСР-10018/18.08.2016; НСР-14456/17.11.2017 02.12.2017 02.01.2018 Неактивен 3376
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1029.82 205.96 1235.78 4% 10 1039.82 207.96 1247.78 16% 25 1064.82 212.96 1277.78 НСР-5078/21.11.2014; НСР-10019/18.08.2016; НСР-14455/17.11.2017 02.12.2017 02.01.2018 Неактивен 3378
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 514.91 102.98 617.89 4% 10 524.91 104.98 629.89 16% 25 549.91 109.98 659.89 НСР-5077/21.11.2014; НСР-13342/28.07.2017 12.08.2017 02.09.2017 Неактивен 3377
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 234.13 46.83 280.96 4% 9.37 243.5 48.7 292.2 16% 25 268.5 53.7 322.2 НСР-5076/21.11.2014; НСР-10018/18.08.2016 03.09.2016 02.10.2016 Неактивен 3376
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1146.76 229.35 1376.11 4% 10 1156.76 231.35 1388.11 16% 25 1181.76 236.35 1418.11 НСР-5078/21.11.2014; НСР-10019/18.08.2016 03.09.2016 02.10.2016 Неактивен 3378
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 583.82 116.76 700.58 4% 10 593.82 118.76 712.58 16% 25 618.82 123.76 742.58 НСР-5077/21.11.2014 08.12.2014 08.12.2014 Неактивен 3377
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 234.6 46.92 281.52 4% 9.38 243.98 48.8 292.78 16% 25 268.98 53.8 322.78 НСР-5076/21.11.2014 08.12.2014 08.12.2014 Неактивен 3376
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1151.79 230.36 1382.15 4% 10 1161.79 232.36 1394.15 16% 25 1186.79 237.36 1424.15 НСР-5078/21.11.2014 08.12.2014 08.12.2014 Неактивен 3378
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1179.27 235.85 1415.12 4% 10 1189.27 237.85 1427.12 16% 25 1214.27 242.85 1457.12 НСР-2939/07.03.2014 25.03.2014 25.03.2014 Неактивен 3378
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 241.27 48.25 289.52 4% 9.65 250.92 50.18 301.1 16% 25 275.92 55.18 331.1 НСР-2941/07.03.2014 25.03.2014 25.03.2014 Неактивен 3376
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 598.62 119.72 718.34 4% 10 608.62 121.72 730.34 16% 25 633.62 126.72 760.34 НСР-2940/07.03.2014 25.03.2014 25.03.2014 Неактивен 3377
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1203.5 240.7 1444.2 4% 10 1213.5 242.7 1456.2 16% 25 1238.5 247.7 1486.2 НСР-434/09.07.2013 30.07.2013 30.07.2013 Неактивен 3378
Tocilizumab EU/1/08/492/001 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 4 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 242.8 48.56 291.36 4% 9.71 252.51 50.5 303.01 16% 25 277.51 55.5 333.01 НСР-436/09.07.2013 30.07.2013 30.07.2013 Неактивен 3376
Tocilizumab EU/1/08/492/003 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 10 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 608.46 121.69 730.15 4% 10 618.46 123.69 742.15 16% 25 643.46 128.69 772.15 НСР-435/09.07.2013 30.07.2013 30.07.2013 Неактивен 3377
Tocilizumab EU/1/08/492/005 RoActemra, Concentrate for solution for infusion, 20 mg/ml - 20 ml, mg, Pack: 1 Roche Registration Limited, Обединено Кралство Roche Pharma AG Germany 1530.38 306.08 1836.46 4% 10 1540.38 308.08 1848.46 16% 25 1565.38 313.08 1878.46 КЦ-1052/22.07.2009 10.08.2009 10.08.2009 Неактивен 3378
Showing 13401 to 13426 of 17770 entries
Download link in CSV format: Copy
Download link in JSON format: Copy
Download link in XML format: Copy
 

Моля изчакайте